US Stock MarketDetailed Quotes

RLAY Relay Therapeutics

Watchlist
  • 6.800
  • +0.220+3.34%
Close Oct 11 16:00 ET
  • 6.604
  • -0.197-2.89%
Post 20:01 ET
1.10BMarket Cap-2698P/E (TTM)

Relay Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Relay Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 10 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 80.000K--
--2024/Q3-- / 80.000K--
Aug 6, 20242024/Q20.000 / 88.890K--
May 2, 20242024/Q110.007M / 109.090K--
Feb 22, 20242023/Q40.000 / 610.000K--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 80.000K--
--2024/Q3-- / 80.000K--
Aug 6, 20242024/Q20.000 / 88.890K--
May 2, 20242024/Q110.007M / 109.090K--
Feb 22, 20242023/Q40.000 / 610.000K--

Unlock Free Earnings Estimates

Relay Therapeutics Earnings Reports

  • Relay Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 6 16:20 ET

  • Relay Therapeutics | 10-Q: Q1 2024 Earnings Report

    May 2 16:20 ET

  • Relay Therapeutics | 10-K: FY2023 Annual Report

    Feb 22 16:25 ET

  • Relay Therapeutics | 10-Q: Q3 2023 Earnings Report

    Nov 2, 2023 16:17 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Oct 12, 2024

    Strong Buy

    • Buy

      90.91%

    • Hold

      9.09%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data